Fontaine, France

Pierre Luc Eymard


Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 138(Granted Patents)


Company Filing History:


Years Active: 1976-1983

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pierre Luc Eymard

Introduction

Pierre Luc Eymard is a notable inventor based in Fontaine, France. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 16 patents to his name, Eymard's work has had a considerable impact on drug formulation and therapeutic applications.

Latest Patents

Eymard's latest patents include innovative polyol derivatives and processes for their preparation. These compounds are utilized in the creation of mono-, di-, tri-, and tetra-esters derived from specific acids. Notably, he has developed pharmaceutically active cyclohexyl compounds that exhibit anticonvulsant and/or antianoxic activity. The chemical compounds he has invented are characterized by a general formula that includes various functional groups, making them versatile for use in medicinal applications.

Career Highlights

Throughout his career, Pierre Luc Eymard has worked with prominent companies such as Labaz and Sanofi. His experience in these organizations has allowed him to refine his expertise in chemical research and development. Eymard's contributions have not only advanced scientific knowledge but have also led to practical applications in the pharmaceutical industry.

Collaborations

Eymard has collaborated with esteemed colleagues, including Charles Pigerol and Jean-Claude Vernieres. These partnerships have fostered a collaborative environment that has enhanced the innovation process and led to the successful development of new chemical compounds.

Conclusion

Pierre Luc Eymard's work exemplifies the spirit of innovation in the field of chemistry. His patents and collaborations have significantly contributed to advancements in pharmaceutical science, showcasing his dedication to improving health outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…